GGrantIndex
Sort

65,743 grants matching single cell sequencing

Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes

$1,145,972
Scarlett L Gomez · University Of California, San Francisco · R01 · FY2020 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$1,145,964
Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy

$1,145,739
Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Regulation And Function Of Retroelements

$1,145,531
Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD

Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine

$1,144,955
Andrea Califano · Columbia University Health Sciences · U01 · FY2019 · CA

Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity

$1,144,825
Geoffrey Myles Wahl · Salk Institute For Biological Studies · R35 · FY2015 · CA

Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung

$1,144,805
W Mark Saltzman · Yale University · UH3 · FY2022 · HL

Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD

$1,144,570
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · R01 · FY2018 · AG

Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort

$1,144,561
Jennifer Gladys Mulle · Rutgers Biomedical And Health Sciences · R01 · FY2024 · MH

Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution

$1,144,522
Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

MOUSE MODELS FOR HUMAN CANCER

$1,144,516
Yeshiva University · U01 · FY2001 · CA

Characterize HIV-Infected T-Cell Clones on ART and Impact of Experimental Interventions

$1,143,693
Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Mechanism of Meiotic Recombination

$1,143,603
Michael J Lichten · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Somatic Mosaicism in the Brain of Tourette Syndrome

$1,143,049
Flora M Vaccarino · Yale University · U01 · FY2019 · MH

A preclinical large animal model for globin gene transfer

$1,143,047
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Determinants of donor-specific T cell tolerance in kidney transplantation in non-sensitized recipients

$1,143,031
Xunrong Luo · Duke University · U19 · FY2024 · AI

Interrogation of individual cells to identify progenitors and their niches

$1,142,961
Irving Lerner Weissman · Stanford University · U01 · FY2009 · HL

NSF-BSF: Studying the relationship between DNA replication and tandem repeat instability

$1,142,847
Sergei M Mirkin · Tufts University · · FY2022 · BIO

1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders

$1,142,697
Zhiping Weng · Univ Of Massachusetts Med Sch Worcester · U01 · FY2019 · MH

1/2 Cross modal integration of molecular and physiological networks in ASD

$1,142,595
Daniel H Geschwind · University Of California Los Angeles · U01 · FY2017 · MH

Chromosomal aberration detection in FFPE tissue using proximity ligation sequencing

$1,141,676
Stephen Matthew Eacker · Phase Genomics, Inc. · R44 · FY2024 · CA

Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease

$1,141,563
Rachel Saunders-Pullman · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · NS

Novel Biologic Therapies for GVHD

$1,141,368
Leslie S Kean · Boston Children'S Hospital · R01 · FY2025 · HL

Epigenetic regulation of neurogenesis

$1,140,193
Hongjun Song · Johns Hopkins University · P01 · FY2016 · NS

In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer

$1,140,175
Jennifer M. Rosenbluth · University Of California, San Francisco · R01 · FY2025 · CA